Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders

Human Molecular Genetics

Volumn 23, Issue 21, 2014, Pages 5683-5705

  Ji, Baohu ^a   Higa, Kerin K ^a   Kim, Minjung ^a   Zhou, Lynn ^b   Young, Jared W ^a,c   Geyer, Mark A ^a,c   Zhou, Xianjin ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b La Jolla High School   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; GLUTAMATE DECARBOXYLASE 67; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; POSTSYNAPTIC DENSITY PROTEIN 95; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RIBOSOME RNA; DISC1FP1 NON-CODING RNA, HUMAN; DLG4 PROTEIN, HUMAN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; HYBRID PROTEIN; MEMBRANE PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NMDA RECEPTOR A1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); SIGNAL PEPTIDE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; BRAIN NERVE CELL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROPOIESIS; FUSION GENE; GENE EXPRESSION; GENE TARGETING; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFORMATION PROCESSING; MAJOR DEPRESSION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ANIMAL; ANIMAL BEHAVIOR; CAUCASIAN; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENE ORDER; GENETICS; MENTAL DISEASE; METABOLISM; PROTEIN SYNTHESIS; TRANSGENIC MOUSE; UNITED KINGDOM;

ANIMALS; BEHAVIOR, ANIMAL; ERYTHROPOIESIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION; GENE ORDER; GENE TARGETING; GLUTAMATE DECARBOXYLASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MENTAL DISORDERS; MICE; MICE, TRANSGENIC; PROTEIN BIOSYNTHESIS; QUINONE REDUCTASES; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT FUSION PROTEINS; SCOTLAND; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84911441976     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu285     Document Type: Article

References (88)

1. St Clair, D., Blackwood, D., Muir, W., Carothers, A., Walker, M., Spowart, G., Gosden, C. and Evans, H.J. (1990) Association within a family of a balanced autosomal translocation with major mental illness. Lancet, 336, 13-16.
2. Blackwood, D.H., Fordyce, A., Walker, M.T., St Clair, D.M., Porteous, D.J. and Muir, W.J. (2001) Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet., 69, 428-433.
3. Millar, J.K., Wilson-Annan, J.C., Anderson, S., Christie, S., Taylor, M.S., Semple, C.A., Devon, R.S., Clair, D.M., Muir, W.J., Blackwood, D.H. et al. (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet., 9, 1415-1423.
4. Kamiya, A., Kubo, K., Tomoda, T., Takaki, M., Youn, R., Ozeki, Y., Sawamura, N., Park, U., Kudo, C., Okawa, M. et al. (2005) A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol., 7, 1167-1178.
5. Duan, X., Chang, J.H., Ge, S., Faulkner, R.L., Kim, J.Y., Kitabatake, Y., Liu, X.B., Yang, C.H., Jordan, J.D., Ma, D.K. et al. (2007) Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell, 130, 1146-1158.
6. Kvajo, M., McKellar, H., Arguello, P.A., Drew, L.J., Moore, H., MacDermott, A.B., Karayiorgou, M. and Gogos, J.A. (2008) A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. U.S.A., 105, 7076-7081.
7. Mao, Y., Ge, X., Frank, C.L., Madison, J.M., Koehler, A.N., Doud, M.K., Tassa, C., Berry, E.M., Soda, T., Singh, K.K. et al. (2009) Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell, 136, 1017-1031.
8. Wang, Q., Charych, E.I., Pulito, V.L., Lee, J.B., Graziane, N.M., Crozier, R.A., Revilla-Sanchez, R., Kelly, M.P., Dunlop, A.J., Murdoch, H. et al. (2011) The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Mol. Psychiatry, 16, 1006-1023.
9. Brandon, N.J. and Sawa, A. (2011) Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci., 12, 707-722.
10. Zhou, X., Geyer, M.A. and Kelsoe, J.R. (2008) Does disrupted-in-schizophrenia (DISC1) generate fusion transcripts? Mol. Psychiatry, 13, 361-363.
11. Zhou, X., Chen, Q., Schaukowitch, K., Kelsoe, J.R. and Geyer, M.A. (2010) Insoluble DISC1-Boymaw fusion proteins generated by DISC1 translocation. Mol. Psychiatry, 15, 669-672.
12. Leliveld, S.R., Bader, V., Hendriks, P., Prikulis, I., Sajnani, G., Requena, J.R. and Korth, C. (2008) Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. J. Neurosci., 28, 3839-3845.
13. Ma, L., Liu, Y., Ky, B., Shughrue, P.J., Austin, C.P. and Morris, J.A. (2002) Cloning and characterization of Disc1, the mouse ortholog of DISC1 (disrupted-in-Schizophrenia 1). Genomics, 80, 662-672.
14. Lipska, B.K., Peters, T., Hyde, T.M., Halim, N., Horowitz, C., Mitkus, S., Weickert, C.S., Matsumoto, M., Sawa, A., Straub, R.E. et al. (2006) Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum. Mol. Genet., 15, 1245-1258.
15. Shaw, G., Morse, S., Ararat, M. and Graham, F.L. (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J., 16, 869-871.
16. Ascano, M. Jr., Mukherjee, N., Bandaru, P., Miller, J.B., Nusbaum, J.D., Corcoran, D.L., Langlois, C., Munschauer, M., Dewell, S., Hafner, M. et al. (2012) FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature, 492, 382-386.
17. Liu, Y., Peterson, D.A., Kimura, H. and Schubert, D. (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem., 69, 581-593.
18. Trevisi, L., Pighin, I., Bazzan, S. and Luciani, S. (2006) Inhibition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) endocytosis by ouabain in human endothelial cells. FEBS Lett., 580, 2769-2773.
19. Berridge, M.V. and Tan, A.S. (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys., 303, 474-482.
20. Stockert, J.C., Blazquez-Castro, A., Canete, M., Horobin, R.W. and Villanueva, A. (2012)MTTassay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochem., 114, 785-796.
21. Terskikh, A., Fradkov, A., Ermakova, G., Zaraisky, A., Tan, P., Kajava, A.V., Zhao, X., Lukyanov, S., Matz, M., Kim, S. et al. (2000) 'Fluorescent timer': protein that changes color with time. Science, 290, 1585-1588.
22. Hung, Y.P., Albeck, J.G., Tantama, M. and Yellen, G. (2011) Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor. Cell Metab., 14, 545-554.
23. Schmidt, E.K., Clavarino, G., Ceppi, M. and Pierre, P. (2009) SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods, 6, 275-277.
24. Santini, E., Huynh, T.N., MacAskill, A.F., Carter, A.G., Pierre, P., Ruggero, D., Kaphzan, H. and Klann, E. (2013) Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature, 493, 411-415.
25. Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., Heninger, G.R., Bowers, M.B.z Jr. and Charney, D.S. (1994) Subanesthetic effects of the noncompetitiveNMDAantagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry, 51, 199-214.
26. Dalmau, J., Gleichman, A.J., Hughes, E.G., Rossi, J.E., Peng, X., Lai, M., Dessain, S.K., Rosenfeld, M.R., Balice-Gordon, R. and Lynch, D.R. (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol., 7, 1091-1098.
27. Iizuka, T., Sakai, F., Ide, T., Monzen, T., Yoshii, S., Iigaya, M., Suzuki, K., Lynch, D.R., Suzuki, N., Hata, T. et al. (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology, 70, 504-511.
28. Gao, X.M., Sakai, K., Roberts, R.C., Conley, R.R., Dean, B. and Tamminga, C.A. (2000) Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry, 157, 1141-1149.
29. Law, A.J. and Deakin, J.F. (2001) Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport, 12, 2971-2974.
30. Volk, D.W., Austin, M.C., Pierri, J.N., Sampson, A.R. and Lewis, D.A. (2000) Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry, 57, 237-245.
31. Hashimoto, T., Volk, D.W., Eggan, S.M., Mirnics, K., Pierri, J.N., Sun, Z., Sampson, A.R. and Lewis, D.A. (2003)Geneexpression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci., 23, 6315-6326.
32. Curley, A.A., Arion, D., Volk, D.W., Asafu-Adjei, J.K., Sampson, A.R., Fish, K.N. and Lewis, D.A. (2011) Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am. J. Psychiatry, 168, 921-929.
33. Tsai, N.P., Wilkerson, J.R., Guo, W., Maksimova, M.A., DeMartino, G.N., Cowan,C.W. and Huber,K.M. (2012) Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell, 151, 1581-1594.
34. Huang, Z.J. (2009) Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond. J. Physiol., 587, 1881-1888.
35. Kuroda, K., Yamada, S., Tanaka, M., Iizuka, M., Yano, H., Mori, D., Tsuboi, D., Nishioka, T., Namba, T., Iizuka, Y. et al. (2011) Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse. Hum. Mol. Genet., 20, 4666-4683.
36. Banbury. (1997) Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on genetic background in mice. Neuron, 19, 755-759.
37. Braff, D.L., Geyer, M.A. and Swerdlow, N.R. (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl), 156, 234-258.
38. Geyer, M.A. and Braff, D.L. (1982) Habituation of the Blink reflex in normals and schizophrenic patients. Psychophysiology, 19, 1-6.
39. Lahti, A.C., Koffel, B., LaPorte, D. and Tamminga, C.A. (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology, 13, 9-19.
40. Holcomb, H.H., Lahti, A.C., Medoff, D.R., Cullen, T. and Tamminga, C.A. (2005) Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology, 30, 2275-2282.
41. Malhotra, A.K., Pinals, D.A., Adler, C.M., Elman, I., Clifton, A., Pickar, D. and Breier, A. (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology, 17, 141-150.
42. Homayoun, H. and Moghaddam, B. (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci., 27, 11496-11500.
43. Moghaddam, B., Adams, B., Verma, A. and Daly, D. (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci., 17, 2921-2927.
44. Risbrough, V.B., Masten, V.L., Caldwell, S., Paulus, M.P., Low, M.J. and Geyer, M.A. (2006) Differential contributions of dopamine D1, D2, and D3 receptors toMDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology, 31, 2349-2358.
45. Steru, L., Chermat, R., Thierry, B. and Simon, P. (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl), 85, 367-370.
46. Cryan, J.F., Mombereau, C. and Vassout, A. (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev., 29, 571-625.
47. Valenstein, E.S., Kakolewski, J.W. and Cox, V.C. (1967) Sex differences in taste preference for glucose and saccharin solutions. Science, 156, 942-943.
48. Horos, R. and von Lindern, M. (2012) Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia. Br. J. Haematol., 159, 514-527.
49. Raabe, B.M., Artwohl, J.E., Purcell, J.E., Lovaglio, J. and Fortman, J.D. (2011) Effects of weekly blood collection in C57BL/6 mice. J. Am. Assoc. Lab. Anim. Sci., 50, 680-685.
50. Duff, B.J., Macritchie, K.A., Moorhead, T.W., Lawrie, S.M. and Blackwood, D.H. (2013) Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr. Res., 147, 1-13.
51. Thomson, P.A., Parla, J.S., McRae, A.F., Kramer, M., Ramakrishnan, K., Yao, J., Soares, D.C., McCarthy, S., Morris, S.W., Cardone, L. et al. (2013) 708Commonand 2010 rareDISC1locus variants identified in 1542 subjects: analysis for association with psychiatric disorder and cognitive traits. Mol. Psychiatry, 19, 668-675.
52. Syntichaki, P., Troulinaki, K. and Tavernarakis, N. (2007) eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans. Nature, 445, 922-926.
53. Eykelenboom, J.E., Briggs, G.J., Bradshaw, N.J., Soares, D.C., Ogawa, F., Christie, S., Malavasi, E.L., Makedonopoulou, P., Mackie, S., Malloy, M.P. et al. (2012) A t(1;11) translocation linked to schizophrenia and affective disorders gives rise to aberrant chimeric DISC1 transcripts that encode structurally altered, deleterious mitochondrial proteins. Hum. Mol. Genet., 21, 3374-3386.
54. Hikida, T., Jaaro-Peled, H., Seshadri, S., Oishi, K., Hookway, C., Kong, S., Wu, D., Xue, R., Andrade, M., Tankou, S. et al. (2007) Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc. Natl. Acad. Sci. USA, 104, 14501-14506.
55. Pletnikov, M.V., Ayhan, Y., Nikolskaia, O., Xu, Y., Ovanesov, M.V., Huang, H., Mori, S., Moran, T.H. and Ross, C.A. (2008) Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol.Psychiatry, 13, 173-186., 115.
56. Hardie, D.G. (2004) The AMP-activated protein kinase pathway--new players upstream and downstream. J. Cell Sci., 117, 5479-5487.
57. Topisirovic, I. and Sonenberg, N. (2011) mRNA translation and energy metabolism in cancer: the role of the MAPK and mTORC1 pathways. Cold Spring Harb. Symp. Quant. Biol., 76, 355-367.
58. Grummt, I. (2003) Life on a planet of its own: regulation ofRNApolymerase I transcription in the nucleolus. Genes Dev., 17, 1691-1702.
59. Ehninger, D., de Vries, P.J. and Silva, A.J. (2009) FrommTORto cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J. Intellect. Disabil. Res., 53, 838-851.
60. Murayama, A., Ohmori, K., Fujimura, A., Minami, H., Yasuzawa-Tanaka, K., Kuroda, T., Oie, S., Daitoku, H., Okuwaki, M., Nagata, K. et al. (2008) Epigenetic control of rDNA loci in response to intracellular energy status. Cell, 133, 627-639.
61. Grummt, I. and Ladurner, A.G. (2008) A metabolic throttle regulates the epigenetic state of rDNA. Cell, 133, 577-580.
62. Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I. and Guarente, L. (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev., 20, 1075-1080.
63. Santoro, M.R., Bray, S.M. and Warren, S.T. (2012) Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu. Rev. Pathol., 7, 219-245.
64. Bhakar, A.L., Dolen, G. and Bear, M.F. (2012) The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci., 35, 417-443.
65. McGowan, P.O., Sasaki, A., Huang, T.C., Unterberger, A., Suderman, M., Ernst, C., Meaney, M.J., Turecki, G. and Szyf, M. (2008) Promoter-wide hypermethylation of the ribosomalRNA gene promoter in the suicide brain. PLoS ONE, 3, e2085.
66. Pietrzak, M., Rempala, G., Nelson, P.T., Zheng, J.J. and Hetman, M. (2011) Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease. PLoS ONE, 6, e22585.
67. Lee, J., Hwang, Y.J., Boo, J.H., Han, D., Kwon, O.K., Todorova, K., Kowall, N.W., Kim, Y. and Ryu, H. (2011) Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease. Cell Death Differ., 18, 1726-1735.
68. Grewal, S.S., Li, L., Orian, A., Eisenman, R.N. and Edgar, B.A. (2005) Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat. Cell Biol., 7, 295-302.
69. Schwanhausser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W. and Selbach, M. (2011) Global quantification of mammalian gene expression control. Nature, 473, 337-342.
70. Vogel, C. (2011) Translation's coming of age. Mol. Syst. Biol., 7, 498.
71. Keyes, S.R. and Cinti, D.L. (1980) Biochemical properties of cytochrome b5-dependent microsomal fatty acid elongation and identification of products. J. Biol. Chem., 255, 11357-11364.
72. Uauy, R., Hoffman, D.R., Peirano, P., Birch, D.G. and Birch, E.E. (2001) Essential fatty acids in visual and brain development. Lipids, 36, 885-895.
73. Ewenczyk, C., Leroux, A., Roubergue, A., Laugel, V., Afenjar, A., Saudubray, J.M., Beauvais, P., Billette de Villemeur, T., Vidailhet, M. and Roze, E. (2008) Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrum. Brain, 131, 760-761.
74. Ji, B., Wang, X., Pinto-Duarte, A., Kim, M., Caldwell, S., Young, J.W., Behrens, M.M., Sejnowski, T.J., Geyer, M.A. and Zhou, X. (2013) Prolonged Ketamine Effects in Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia. PLoS ONE, 8, e66327.
75. Braff, D.L., Grillon, C. and Geyer, M.A.(1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry, 49, 206-215.
76. Swerdlow, N.R., Shoemaker, J.M., Auerbach, P.P., Pitcher, L., Goins, J. and Platten, A. (2004) Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology (Berl), 174, 452-462.
77. Swerdlow, N.R., Lelham, S.A., Sutherland Owens, A.N., Chang, W.L., Sassen, S.D. and Talledo, J.A. (2009) Pramipexole effects on startle gating in rats and normal men. Psychopharmacology (Berl), 205, 689-698.
78. May, H.T., Anderson, J.L., Muhlestein, J.B., Bair, T.L., Knight, S. and Horne, B.D. (2013) Red Cell Distribution Width and Depression Among Patients Undergoing Angiography. Circulation, 128, S314.
79. Bochkov, Y.A. and Palmenberg, A.C. (2006) Translational efficiency of EMCV IRES in bicistronic vectors is dependent upon IRES sequence and gene location. BioTechniques, 41, 283-284., 286, 288 passim.
80. Zhou, X., Barrett, T.B. and Kelsoe, J.R. (2008) Promoter variant in theGRK3 gene associated with bipolar disorder alters gene expression. Biol. Psychiatry, 64, 104-110.
81. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J.Immunol. Methods, 65, 55-63.
82. Ji, B., La, Y., Gao, L., Zhu, H., Tian, N., Zhang, M., Yang, Y., Zhao, X., Tang, R., Ma, G. et al. (2009) A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications. J. Proteome Res., 8, 3633-3641.
83. Kim, M., Soontornniyomkij, V., Ji, B. and Zhou, X. (2012) System-wide immunohistochemical analysis of protein co-localization. PLoS ONE, 7, e32043.
84. Collins, M.L., Irvine, B., Tyner, D., Fine, E., Zayati, C., Chang, C., Horn, T., Ahle, D., Detmer, J., Shen, L.P. et al. (1997) A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res., 25, 2979-2984.
85. Player, A.N., Shen, L.P., Kenny, D., Antao, V.P. and Kolberg, J.A. (2001) Single-copy gene detection using branched DNA (bDNA) in situ hybridization. J. Histochem. Cytochem., 49, 603-612.
86. Acheson, D.T., Stein, M.B., Paulus, M.P., Geyer, M.A. and Risbrough, V.B. (2012) The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice. Neuropharmacology, 63, 480-485.
87. Flaisher-Grinberg, S., Overgaard, S. and Einat, H. (2009) Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania. J. Neurosci. Methods, 177, 44-50.
88. Tanaka, S., Young, J.W., Halberstadt, A.L., Masten, V.L. and Geyer, M.A. (2012) Four factors underlying mouse behavior in an open field. Behav. Brain Res., 233, 55-61.